Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126023631 | 12602363 | 1 | I | 20160531 | 0 | 20160727 | 20160727 | DIR | 59.00 | YR | F | N | 0.00000 | 20160602 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126023631 | 12602363 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 600 MG EVERY 4 HOURS PO | N | N | 0 | 600 | MG | Q4H | |||||
| 126023631 | 12602363 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 5 | C | BISACODYL. | BISACODYL | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 7 | C | BRIMONIDINE | BRIMONIDINE TARTRATE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 9 | C | DOCUSATE | DOCUSATE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 13 | C | LATANOPROST. | LATANOPROST | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 15 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 17 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 19 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 21 | C | OXYCODONE-ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 23 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 25 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 27 | C | SODIUM PHOSPHATE | SODIUM PHOSPHATE | 1 | 0 | ||||||||||||
| 126023631 | 12602363 | 29 | C | TIMOLOL OPTHALMIC | 2 | 0 | |||||||||||||
| 126023631 | 12602363 | 31 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126023631 | 12602363 | 1 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126023631 | 12602363 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126023631 | 12602363 | Duodenal ulcer | |
| 126023631 | 12602363 | Haematemesis | |
| 126023631 | 12602363 | Hypotension | |
| 126023631 | 12602363 | Seizure | |
| 126023631 | 12602363 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126023631 | 12602363 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126023631 | 12602363 | 1 | 20160531 | 0 |